journal
Journals Prostate Cancer and Prostatic ...

Prostate Cancer and Prostatic Diseases

https://read.qxmd.com/read/36914851/correction-to-association-between-adherence-to-radiation-therapy-quality-metrics-and-patient-reported-outcomes-in-prostate-cancer
#1
Jacob E Tallman, Christopher J D Wallis, Li-Ching Huang, Zhiguo Zhao, David F Penson, Tatsuki Koyama, Ralph Conwill, Michael Goodman, Ann S Hamilton, Xiao-Cheng Wu, Lisa E Paddock, Antoinette Stroup, Matthew R Cooperberg, Mia Hashibe, Brock B O'Neil, Sherrie H Kaplan, Sheldon Greenfield, Daniel A Barocas, Karen E Hoffman
No abstract text is available yet for this article.
March 13, 2023: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/36899091/correction-overall-survival-and-adverse-events-after-treatment-with-darolutamide-vs-apalutamide-vs-enzalutamide-for-high-risk-non-metastatic-castration-resistant-prostate-cancer-a-systematic-review-and-network-meta-analysis
#2
Mike Wenzel, Luigi Nocera, Claudia Collà Ruvolo, Christoph Würnschimmel, Zhe Tian, Shahrokh F Shariat, Fred Saad, Derya Tilki, Markus Graefen, Luis A Kluth, Alberto Briganti, Philipp Mandel, Francesco Montorsi, Felix K H Chun, Pierre I Karakiewicz
No abstract text is available yet for this article.
March 10, 2023: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/36890265/correction-to-prostate-volume-baseline-urinary-function-and-their-association-with-treatment-choice-and-post-treatment-urinary-function-in-men-treated-for-localized-prostate-cancer
#3
Jacob E Tallman, Christopher J D Wallis, Zhiguo Zhao, Li-Ching Huang, David F Penson, Tatsuki Koyama, Michael Goodman, Ann S Hamilton, Xiao-Cheng Wu, Lisa E Paddock, Antoinette Stroup, Matthew R Cooperberg, Mia Hashibe, Brock B O'Neil, Sherrie H Kaplan, Sheldon Greenfield, Karen E Hoffman, Daniel A Barocas
No abstract text is available yet for this article.
March 8, 2023: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/36872319/the-imperative-for-clinical-trial-diversity-perspectives-in-the-context-of-prostate-specific-membrane-antigen-targeted-imaging
#4
REVIEW
Hae Lin Cho, Subha Perni, Anthony V D'Amico, Kosj Yamoah, Edward Christopher Dee
No abstract text is available yet for this article.
March 6, 2023: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/36859711/length-of-positive-surgical-margins-after-radical-prostatectomy-does-size-matter-a-systematic-review-and-meta-analysis
#5
REVIEW
Athul John, Alicia Lim, Rick Catterwell, Luke Selth, Michael O'Callaghan
OBJECTIVES: The prognostic capacity of positive surgical margins (PSM) for biochemical recurrence (BCR) is unclear, with inconsistent findings across published studies. We aimed to systematically review and perform a meta-analysis exploring the impact of Positive surgical margin length on biochemical recurrence in men after radical prostatectomy. METHODS: A search was conducted using the MEDLINE, Scopus, Embase and Cochrane databases according to the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines...
March 1, 2023: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/36854805/antimicrobial-prophylaxis-to-do-or-not-to-do-this-is-the-question
#6
EDITORIAL
Tommaso Cai
No abstract text is available yet for this article.
February 28, 2023: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/36849728/radiation-technique-and-outcomes-following-moderately-hypofractionated-treatment-of-low-risk-prostate-cancer-a-secondary-analysis-of-rtog-0415
#7
JOURNAL ARTICLE
David J Carpenter, Joseph K Salama, W Robert Lee, Matthew J Boyer
BACKGROUND: While moderately hypofractionated radiotherapy (MHRT) for prostate cancer (PC) is commonly delivered by intensity modulated radiation therapy, IMRT has not been prospectively compared to three-dimensional conformal radiotherapy (3D-CRT) in this context. We conducted a secondary analysis of the phase III RTOG 0415 trial comparing survival and toxicity outcomes for low-risk PC following MHRT with IMRT versus 3D-CRT. METHODS: RTOG 0415 was a phase III, non-inferiority trial randomizing low-risk PC patients to either MHRT or conventionally fractionated radiation with stratification by RT technique...
February 27, 2023: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/36782018/reply-to-fact-overdiagnosis-cannot-be-evaluated-by-comparing-histological-grading-of-prostate-biopsy-to-prostatectomy-specimen
#8
LETTER
Alberto Martini, Guillaume Ploussard
No abstract text is available yet for this article.
February 13, 2023: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/36765111/the-natural-history-of-a-delayed-detectable-psa-after-radical-prostatectomy
#9
JOURNAL ARTICLE
Julie A Szymaniak, Samuel L Washington, Janet E Cowan, Matthew R Cooperberg, Peter E Lonergan, Hao G Nguyen, Maxwell V Meng, Peter R Carroll
INTRODUCTION: Men with a detectable PSA after radical prostatectomy (RP) are often offered salvage therapy while those with an undetectable PSA are monitored. We aim to better characterize the natural history of men with an initially undetectable PSA who subsequently developed a detectable PSA > 6 months after RP. METHODS: Retrospective analysis of men who underwent RP for clinically localized prostate cancer at the University of California, San Francisco from 2000 to 2022...
February 10, 2023: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/36739329/best-of-2022-in-prostate-cancer-and-prostatic-diseases
#10
EDITORIAL
Cosimo De Nunzio, Riccardo Lombardo
No abstract text is available yet for this article.
February 4, 2023: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/36732363/working-hard-or-hardly-working-a-brief-commentary-of-latest-research-on-exercise-and-prostate-cancer
#11
EDITORIAL
Gloria Cecilia Galván, Sanjay Das, James P Daniels, Nadine A Friedrich, Stephen J Freedland
No abstract text is available yet for this article.
February 2, 2023: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/36732362/a-healthy-diet-a-healthy-prostate-a-brief-commentary-on-the-latest-research-on-diet-and-prostate-cancer
#12
EDITORIAL
Gloria Cecilia Galván, James P Daniels, Nadine A Friedrich, Sanjay Das, Stephen J Freedland
No abstract text is available yet for this article.
February 2, 2023: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/36732361/understanding-biochemical-recurrence-after-radical-prostatectomy-trust-biology-not-a-number
#13
EDITORIAL
Simone Albisinni, Romain Diamand
No abstract text is available yet for this article.
February 2, 2023: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/36717642/price-transparency-of-prostate-cancer-care-in-the-united-states-an-analysis-of-pricing-and-disclosure-following-the-centers-for-medicare-and-medicaid-mandate
#14
JOURNAL ARTICLE
Aaron Brant, Patrick Lewicki, Stephen Rhodes, Camilo Arenas-Gallo, Mary O Strasser, Alec Zhu, Lee Ponsky, Jonathan E Shoag
BACKGROUND: Starting January 1, 2021, Centers for Medicare and Medicaid Services required United States hospitals to publicly disclose prices of their services provided. We analyzed publicly-disclosed prices of prostate cancer-related services. METHODS: All United States hospitals were queried for publicly-disclosed prices of total and free prostate-specific antigen, prostate magnetic resonance imaging, prostate biopsy, radical prostatectomy, and intensity-modulated radiation therapy as of May 2022...
January 30, 2023: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/36709235/treatment-decision-making-among-patients-with-metastatic-prostate-cancer-impact-of-decision-locus-of-control-on-functional-outcomes-and-decision-satisfaction
#15
JOURNAL ARTICLE
Frank A Schumacher, Irene B Helenowski, Zequn Sun, Laura B Oswald, Brian D Gonzalez, Kelvin A Moses, James T Benning, Alicia K Morgans
BACKGROUND: Shared decision-making (SDM) for metastatic prostate cancer (mPC) engages patients in the decision-making process and may be associated with better outcomes relative to physician- or patient-directed decision-making. We assessed the association between decision locus of control (DLOC) and patient-reported quality of life (QOL), functional outcomes, and decision satisfaction among mPC patients. METHODS: After a clinic visit in which a treatment decision was made (baseline), mPC patients completed DLOC and QOL surveys...
January 28, 2023: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/36697921/mobile-health-a-promising-tool-for-the-management-of-male-patients-with-lower-urinary-tract-symptoms-suggestive-of-benign-prostatic-hyperplasia
#16
REVIEW
Massimiliano Creta, Celeste Manfredi, Davide Arcaniolo, Marco De Sio, Nicola Longo, Cosimo De Nunzio, Ferdinando Fusco
No abstract text is available yet for this article.
January 25, 2023: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/36681741/usefulness-of-podcasts-to-provide-public-education-on-prostate-cancer-genetics
#17
JOURNAL ARTICLE
Stacy Loeb, Tatiana Sanchez Nolasco, Katherine Siu, Nataliya Byrne, Veda N Giri
BACKGROUND: Podcasts, or episodic digital audio recordings, represent a novel way to reach large audiences for public education. Genetic evaluation has important implications for prostate cancer (PCa) care but is underutilized. We created a series of five podcasts about PCa genetics and tested their usefulness in raising awareness and providing education to lay audiences. METHODS: We recruited 157 men and women from the general public and 100 patients with PCa from across the U...
January 21, 2023: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/36670304/correction-to-overdiagnosis-and-stage-migration-of-isup-2-disease-due-to-mpmri-targeted-biopsy-facts-or-fictions
#18
Alberto Martini, Alae Touzani, Elio Mazzone, Mathieu Roumiguié, Giancarlo Marra, Massimo Valerio, Jean Baptiste Beauval, Riccardo Campi, Andrea Minervini, Roderick C N van den Berg, Timo F W Soeterik, Junlong Zhuang, Hongqian Guo, Paolo Gontero, Francesco Montorsi, Alberto Briganti, Giorgio Gandaglia, Guillame Ploussard
No abstract text is available yet for this article.
January 20, 2023: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/36641534/revisiting-current-national-comprehensive-cancer-network-nccn-high-risk-prostate-cancer-stratification-a-national-cancer-database-analysis
#19
JOURNAL ARTICLE
Harshit Garg, Furkan Dursun, Fadi Alsayegh, Hanzhang Wang, Shenghui Wu, Michael A Liss, Dharam Kaushik, Robert S Svatek, Ahmed M Mansour
BACKGROUND: High-risk prostate cancer includes heterogenous populations with variable outcomes. This study aimed to compare the prognostic ability of individual high-risk factors, as defined by National Comprehensive Cancer Network (NCCN) risk stratification, in prostate cancer patients undergoing radical prostatectomy. METHODS: We queried the National Cancer Database from 2004 to 2018 for patients with non-metastatic high-risk prostate cancer who underwent radical prostatectomy and stratified them as Group H1: Prostate specific antigen (PSA) > 20 ng/ml alone, Group H2: cT3a stage alone and Group H3: Gleason Grade (GG) group 4/5 as per NCCN guidelines...
January 14, 2023: Prostate Cancer and Prostatic Diseases
https://read.qxmd.com/read/36641533/cardiovascular-adverse-events-related-to-gnrh-agonists-and-gnrh-antagonists-analysis-of-real-life-data-from-eudra-vigilance-and-food-and-drug-administration-databases-entries
#20
JOURNAL ARTICLE
Antonio Cicione, Antonio Nacchia, Alessandro Guercio, Carmen Gravina, Antonio Franco, Maria Chiara Grimaldi, Giorgia Tema, Riccardo Lombardo, Andrea Tubaro, Cosimo De Nunzio
INTRODUCTION AND OBJECTIVES: GnRH agonists and GnRH antagonists are two of the mainstays of hormonal therapy (HT) for prostate cancer (PCa). These drugs are at increased risk of cardiovascular (CV) adverse events (AEs). Aim of our study was to compare real-life data on AEs associated with GnRH agonists and GnRH antagonists based on Eudra-Vigilance (EV) and Food and Drug Administration (FDA) reported AEs. MATERIALS AND METHODS: EV and FDA databases were queried and the number of CV adverse events (AEs) for degarelix, buserelin, goserelin, leuprorelin, triptorelin until September 2021 were recorded...
January 14, 2023: Prostate Cancer and Prostatic Diseases
journal
journal
33118
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.